6 results
To compare the efficacy of two dose levels of erlotinib (150 mg and 300 mg) on progression-free survival (PFS) in current smokers with stage IIIB/IV NSCLC after failure of first-line platinum-based chemotherapy.
In this study we want to determine the activity and safety of concurrent interruption of the MAPK and PI3K pathways by the EGFR tyrosine kinase inhibitor erlotinb and metformin, combined with gemcitabine in patients with metatastatic pancreatic…
To assess the applicability of robotic-assisted microsurgery in replantation of amputated digits due to trauma.
This study will assess the applicability of robotic-assisted microsurgery in DNR after trauma.
Compare neurophysiological biomarkers with symptom control and stimulation parameters to improve stimulation settings for individual patients with Parkinson*s disease, tremor syndromes and dystonia.
To assess the applicability of robotic-assisted microsurgery in replantation of amputated digits due to trauma.